Evidence map›Paper›PMID 30558549›Full record

ArticleBMC infectious diseases2018

Endogenous endophthalmitis caused by a multidrug-resistant hypervirulent Klebsiella pneumoniae strain belonging to a novel single locus variant of ST23: first case report in China.

Min Xu, Ang Li, Haishen Kong, Weili Zhang, Hongchao Chen, Yajie Fu, Yiqi Fu

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 42 citations in OpenAlex.

  1. A review of bloodstream infections-pathogens, pathogenesis, diagnostic strategies, treatment methods-challenges and future aspects.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Review
  2. Review
  3. Hypervirulent and Drug-ResistantInternational journal of general medicine · 2026
    Review
  4. Article
  5. HypervirulentPharmaceuticals (Basel, Switzerland) · 2025
    Review
  6. Article
  7. Review
  8. A mini case report:Heliyon · 2024
    Article
  9. HypervirulentPathogens & immunity · 2024
    Review
  10. Article
  11. Review
  12. A rare case of concomitantAnnals of medicine and surgery (2012) · 2023
    Article
  13. Review
  14. Article
  15. Article
  16. The invasiveJournal of Taibah University Medical Sciences · 2022
    Article
  17. Article
  18. Article
  19. HypervirulentLife (Basel, Switzerland) · 2021
    Review
  20. Clinical Challenges with HypervirulentJournal of translational internal medicine · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Min XuKey Laboratory of Clinical In Vitro Diagnostic Techniques of Zhejiang Province, Center of Clinical Laboratory, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Ang LiDepartment of Precision Medicine Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Haishen KongKey Laboratory of Clinical In Vitro Diagnostic Techniques of Zhejiang Province, Center of Clinical Laboratory, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Weili ZhangKey Laboratory of Clinical In Vitro Diagnostic Techniques of Zhejiang Province, Center of Clinical Laboratory, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Hongchao ChenKey Laboratory of Clinical In Vitro Diagnostic Techniques of Zhejiang Province, Center of Clinical Laboratory, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Yajie FuKey Laboratory of Clinical In Vitro Diagnostic Techniques of Zhejiang Province, Center of Clinical Laboratory, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Yiqi FuDepartment of Respiratory Diseases, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China. fuyiqi@zju.edu.cn.
Zhejiang University · CNFirst Affiliated Hospital of Zhengzhou University · CN

Funding

Medical Science and Technology Project of Zhejiang Province no. 2014KYB096National Key Program for Infectious Diseases of China no. 2017ZX10103008National Natural Science Foundation of China no. 81301459Natural Science Foundation of Zhejiang Province no. LQ13H190001
6 · The paper itself

Abstract

backgroundEndogenous endophthalmitis caused by hypervirulent Klebsiella pneumoniae (HVKP) is an emerging infectious disease commonly with a devastating visual outcome. Most HVKP strains display a wild-type susceptibility profile to antibiotics. However, reports of antimicrobial-resistant HVKP have increased over time, which poses a serious therapeutic dilemma. CASE PRESENTATION: A 25-year-old man with a liver abscess and poorly controlled diabetes mellitus was admitted for endophthalmitis due to K. pneumoniae. The isolate displayed hypermucoviscosity as determined by a positive string test and exhibited resistance to ceftazidime, piperacillin-tazobactam and amikacin. Whole genome sequencing (WGS) analysis demonstrated the isolate to be a K1-serotype strain and belong to a novel single locus variant of ST23, ST2922. In addition to the virulence genes linked to HVKP, rmpA, magA, iucABCDiutA (aerobactin), ybtAPSTUX (yersiniabactin) and iroBDN (salmochelin), it was found to harbor extended-spectrum β-lactamase (ESBL) gene (bla

conclusionsThis is the first known case of endogenous endophthalmitis caused by a multidrug-resistant HVKP strain ever reported in China. Early diagnosis and treatment with intravenous and intravitreal injection of carbapenem were essential for a favorable visual outcome.

Indexed as

Drug Resistance, Multiple, BacterialAdultBacterial Proteinsbeta-LactamasesChinaCommunicable Diseases, EmergingEndophthalmitisEye Infections, BacterialGenetic LociHumansKlebsiella InfectionsKlebsiella pneumoniaeLiver AbscessMaleRNA, Ribosomal, 16SVirulenceAmpC beta-lactamasesBacterial Proteinsbeta-LactamasesRNA, Ribosomal, 16SVirulence FactorsAmpCEndophthalmitisESBLHypervirulentKlebsiella pneumoniae

Identifiers

PMID30558549
PMCPMC6296127
OpenAlexW2904510940

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.